Date | Total number of repurchased shares | Weighted average purchase price (EUR) |
December 13, 2017 | 435,000 | 32.92 |
December 14, 2017 | 650,578 | 32.67 |
December 15, 2017 | 305,000 | 32.54 |
December 18, 2017 | 70,000 | 33.07 |
December 19, 2017 | 850,000 | 33.19 |
December 20, 2017 | 900,000 | 32.40 |
December 21, 2017 | 680,000 | 31.79 |
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office
Tel: +31 6 1521 3446
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
Philips Investor Relations
Tel: +31 20 59 77055
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.